Gonorrhea News and Research

RSS
Gonorrhea is a very common sexually transmitted disease (STD) caused by the bacteria Neisseria gonorrhea. It is estimated that 820,000 new cases of gonorrhea are diagnosed in the U.S. every year.

Gonorrhea is usually transmitted during vaginal, oral or anal sex or through sharing sex aids that have not been washed or covered with a condom each time they are used. A mother can also pass the infection onto her baby during childbirth, which can cause blindness in the infant.

Common symptoms in men include a burning sensation when urinating and a white, yellow, or green discharge from the penis, although some men may have no symptoms. Women with gonorrhea do not usually have any symptoms but initial symptoms may include pain or burning on urination, increased vaginal discharge, vaginal bleeding between periods and abdominal and pelvic pain.

If a woman is left untreated, infection can spread into the womb and fallopian tubes causing pelvic inflammatory disease which can lead to infertility and an increased risk for ectopic pregnancy. In men, the disease can cause epididymitis, a painful swelling in the back of the testicles that can also eventually lead to infertility.

Gonorrhea is identified using a urine test or swabs taken from a man’s urethra or a woman’s cervix. Antibiotics can be used to stop infection but cannot repair any permanent damage caused by the disease.
Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

The state of sexually transmissible and blood-borne infections in Australia: the 2010 Surveillance Reports

The state of sexually transmissible and blood-borne infections in Australia: the 2010 Surveillance Reports

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Condoms can prevent transmission of herpes simplex virus 2: Study

Condoms can prevent transmission of herpes simplex virus 2: Study

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Safe sex campaign for over 50’s

Safe sex campaign for over 50’s

Abbott RealTime HBV assay receives marketing approval from FDA

Abbott RealTime HBV assay receives marketing approval from FDA

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Gen-Probe second-quarter 2010 product sales up 14%

Gen-Probe second-quarter 2010 product sales up 14%

Abbot's innovative solutions to be highlighted at AACC

Abbot's innovative solutions to be highlighted at AACC

Abbott second-quarter global sales increase 17.8% to $8.8 billion

Abbott second-quarter global sales increase 17.8% to $8.8 billion

Cash rewards help combat STIs in rural Africa, study finds

Cash rewards help combat STIs in rural Africa, study finds

Gen-Probe's APTIMA Trichomonas assay receives European CE mark

Gen-Probe's APTIMA Trichomonas assay receives European CE mark

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Advanced Life Sciences expands partnership with U.S. Government to assess Restanza against STI's

Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections

Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV

Gen-Probe reports total revenues of $135.4M for first-quarter 2010

Gen-Probe reports total revenues of $135.4M for first-quarter 2010

Gonorrhea may soon become untreatable according to WHO

Gonorrhea may soon become untreatable according to WHO